137 related articles for article (PubMed ID: 20586927)
1. Achieving ultimate control of hepatitis B infection in China: progress and challenges.
Jia JD; Yao GB
J Viral Hepat; 2010 Mar; 17 Suppl 1():2-3. PubMed ID: 20586927
[No Abstract] [Full Text] [Related]
2. Management of hepatitis B in China.
Lu FM; Zhuang H
Chin Med J (Engl); 2009 Jan; 122(1):3-4. PubMed ID: 19187608
[No Abstract] [Full Text] [Related]
3. Progress in the prevention and control of viral hepatitis type B: closing remarks.
Rizzetto M; Zanetti AR
J Med Virol; 2002 Jul; 67(3):463-6. PubMed ID: 12116047
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and prevention of hepatitis B virus infection in China.
Lu FM; Li T; Liu S; Zhuang H
J Viral Hepat; 2010 Mar; 17 Suppl 1():4-9. PubMed ID: 20586928
[TBL] [Abstract][Full Text] [Related]
5. [Progress and challenges in achieving the WHO goal on 'Elimination of Hepatitis B by 2030' in China].
Liu J; Liu M
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jun; 40(6):605-609. PubMed ID: 31238605
[TBL] [Abstract][Full Text] [Related]
6. Control of hepatitis B in China: prevention and treatment.
Wang Y; Jia J
Expert Rev Anti Infect Ther; 2011 Jan; 9(1):21-5. PubMed ID: 21171874
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B in children.
Broderick AL; Jonas MM
Semin Liver Dis; 2003 Feb; 23(1):59-68. PubMed ID: 12616451
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus infection.
Margolis HS
Bull World Health Organ; 1998; 76 Suppl 2(Suppl 2):152-3. PubMed ID: 10063701
[No Abstract] [Full Text] [Related]
9. Hepatitis B virus: is a cure possible?
Zeisel MB; Baumert TF
Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1129-30. PubMed ID: 27347775
[No Abstract] [Full Text] [Related]
10. Hepatitis B immunisation leads to the decline of hepatitis B virus prevalence in Gansu province, China.
Liu C; Li H; Gao L; Li F; Liang X; Yang K
Aust N Z J Public Health; 2011 Feb; 35(1):91-2. PubMed ID: 21299712
[No Abstract] [Full Text] [Related]
11. On the way towards the eradication of chronic hepatitis B.
Ren H
J Viral Hepat; 2019 Jul; 26 Suppl 1():3-4. PubMed ID: 31380587
[No Abstract] [Full Text] [Related]
12. Hepatitis B vaccines: protective efficacy and therapeutic potential.
Michel ML; Tiollais P
Pathol Biol (Paris); 2010 Aug; 58(4):288-95. PubMed ID: 20382485
[TBL] [Abstract][Full Text] [Related]
13. The role of the GAVI Alliance in improving childhood hepatitis B vaccination in China: successes, lessons learned, and future global challenges.
Averhoff F; Kolwaite A; Ward JW
Vaccine; 2013 Dec; 31 Suppl 9():J5-7. PubMed ID: 23623862
[No Abstract] [Full Text] [Related]
14. Hepatitis B immunization after liver transplantation: what is the answer?
Poland GA; Poterucha JJ
Liver Transpl; 2005 Oct; 11(10):1181-3. PubMed ID: 16184563
[No Abstract] [Full Text] [Related]
15. Current status of liver diseases in Korea: hepatitis B.
Chae HB; Kim JH; Kim JK; Yim HJ
Korean J Hepatol; 2009 Dec; 15 Suppl 6():S13-24. PubMed ID: 20037275
[TBL] [Abstract][Full Text] [Related]
16. The next step in controlling HBV in China.
Xu Y; Liu H; Wang Y; Hao R; Li Z; Song H
BMJ; 2013 Jul; 347():f4503. PubMed ID: 23861426
[No Abstract] [Full Text] [Related]
17. Prevention of hepatitis B in China: achievements and challenges.
Lu FM; Zhuang H
Chin Med J (Engl); 2009 Dec; 122(24):2925-7. PubMed ID: 20137475
[No Abstract] [Full Text] [Related]
18. The China GAVI Project.
Berkley S
Vaccine; 2013 Dec; 31 Suppl 9():J3-4. PubMed ID: 24331018
[No Abstract] [Full Text] [Related]
19. [Promoting hepatitis B elimination and laying emphasis on its economics evaluation].
Zhang SX
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):841-844. PubMed ID: 28738453
[TBL] [Abstract][Full Text] [Related]
20. Foreword. Hepatitis B and the impact of immunization in China and the WHO Western Pacific Region.
Yu W
Vaccine; 2013 Dec; 31 Suppl 9():J2. PubMed ID: 24331016
[No Abstract] [Full Text] [Related]
[Next] [New Search]
